Table 1.
Demographic characteristics participants by HBV infection status (N = 2419)
| Demographic Characteristics | HIV N = 2220 |
HIV-HBV Co-Infection N = 199 |
p valuea |
|---|---|---|---|
| Median Age | 40 (32.0–46.0) | 39 (33.0–45.0) | 0.69 |
| Male Sex | 1806 (81) | 164 (82) | 0.71 |
| Deceased | 150 (7) | 22 (11) | 0.02 |
| Ethnicity | |||
| White | 967 (44) | 78 (39) | 0.11 |
| Black | 408 (18) | 50 (25) | |
| Indigenous | 138 (6) | 10 (5) | |
| Asian | 147 (7) | 20 (10) | |
| Hispanic | 116 (5) | 9 (5) | |
| Other | 82 (4) | 5 (3) | |
| Unknown | 362 (16) | 27 (14) | |
| Province | |||
| BC | 946 (43) | 88 (44) | 0.49 |
| ON | 870 (39) | 70 (35) | |
| QC | 404 (18) | 41 (21) | |
| Risk Factors | |||
| MSM | 998 (45) | 93 (47) | 0.63 |
| PWID | 467 (21) | 55 (28) | 0.03 |
BC British Colombia, ON Ontario, QC Quebec, MSM Men who have sex with men, PWID people who inject drugs, ADI AIDS defining illness, ARV anti-retroviral therapy
aData shown are frequencies and proportions for categorical variables and median and interquartile ranges for continuous variables. p values for categorical variables were calculated using chi-square or Fisher exact tests and for continuous variables were calculated using Wilcoxon’s Rank Sum tests
b‘No ADI ever’ refers to no recorded ADI’s during study period. ‘None before/or first ARV date’ refers to no recoded ADI prior to study enrollment